COVID VACCINE INVESTING. Up to date information about the smaller bio-pharmaceutical companies developing a COVID vaccine. This blog features a COVID INVESTOR INDEX which keeps track of the relative performance of 28 key COVID VACCINE companies.
Tuesday 8 February 2022
Small loss of 1.8% overall - Novavax stumbles 12%
Stocks edged downward, falling 1.8% overall with 17 losers and nine winners.
Novavax lead on the way down with a 12%. BioNTech fell 7% and TNXP fell 6%.
No comments:
Post a Comment